AnaptysBio, Inc. logo

ANABAnaptysBio, Inc.

ANAB Stock Price, Valuation & Chart | AnaptysBio, Inc.

Compare

ANAB Historical price chart

ANAB Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization1.73B
PE Ratio-54.05
EPS-1.08
Trading Volume294.61K
Today's High/Low58.99/56.8
Dividend Yield0.00
52 Week High/Low72.36/11.4
Shares Outstanding29.61M
ANAB Financial Statement
ANAB Analyst ratings
ANAB Analysis & performance metrics

ANAB Company profile

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products…

ANAB Management team

Management
Benjamin Stone
Chief Business Officer
Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D.
Chief Medical Officer
Martin Dahl Ph.D.
Senior Vice President of Research
Daniel R. FagaCEO
President, Chief Executive Officer & Director
Douglas A. Rich M.B.A.
Senior Vice President of CMC
Beth Mueller
Senior Vice President of Human Resources
Monique Da Silva
Senior Vice President of Corporate Affairs
Eric J. Loumeau
Chief Legal Officer
Total 8 executives

ANAB Frequently asked questions

What is AnaptysBio, Inc. (ANAB) Stock Price?

Current stock price of AnaptysBio, Inc. (ANAB) stock is $58.370. The stock price is -0.12% lower in the session. The intraday range can be seen from this page. Volume of AnaptysBio, Inc. (ANAB) stock is 294.61K.

Last updated at 25 Aug 2026, 08:00 pm.

Why is the AnaptysBio, Inc. (ANAB) stock price going up or down today?

The stock price of AnaptysBio, Inc. (ANAB) can change with earnings, company news, and overall market sentiment. AnaptysBio, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the AnaptysBio, Inc. stock expensive at its current price?

Whether AnaptysBio, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ANAB on this page is -54.05. EPS on this page is -1.08. Compare those figures with peers and growth expectations before deciding if the current AnaptysBio, Inc. price is justified.

How has the stock price of AnaptysBio, Inc. (ANAB) performed historically?

Historical performance for AnaptysBio, Inc. (ANAB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ANAB reacted to past earnings and market events.

Should I buy AnaptysBio, Inc. (ANAB) stock, at this price?

Buying AnaptysBio, Inc. (ANAB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.